Who owns EUPRAXIA PHARMACEUTICALS INC?
- Ticker: EPRX
- CUSIP Number: 29842p105
Tip: Access positions for across all investors
Analyze quarterly positions in Eupraxia Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eupraxia Pharmaceuticals stock
Who bought or sold EUPRAXIA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Beutel, Goodman & Company | 3.6M | $24M | -1% | Jun 2026 |
|
| Affinity Asset Advisors | 1.7M | $11M | 4% | Jun 2026 |
|
| Balyasny Asset Management | 1.4M | $9.8M | 0% | Mar 2026 |
|
| Vivo Capital | 1.4M | $9.8M | 0% | Mar 2026 |
|
| Scotia Capital | 1.3M | $8.8M | 0% | Jun 2026 |
|
| Partner Fund Management | 1.2M | $8.0M | 124% | Jun 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.2M | $7.9M | 0% | Jun 2026 |
|
| Jupiter Topco | 1.0M | $6.9M | 100% | Jun 2026 |
|
| Ikarian Capital | 810k | $5.4M | -33% | Jun 2026 |
|
| UBS Group | 763k | $5.5M | 247% | Mar 2026 |
|
| Point72 Asset Management | 730k | $4.8M | -25% | Jun 2026 |
|
| Rubric Capital Management | 691k | $5.0M | 100% | Mar 2026 |
|
| Ameriprise Financial | 649k | $4.7M | 100% | Mar 2026 |
|
| Redmile Group | 611k | $4.0M | -13% | Jun 2026 |
|
| Citadel Advisors | 502k | $3.3M | 118% | Jun 2026 |
|
| Woodline Partners | 441k | $3.2M | 100% | Mar 2026 |
|
| Seven Fleet Capital Management | 434k | $3.1M | 100% | Mar 2026 |
|
| Alyeska Investment Group | 375k | $2.7M | 100% | Mar 2026 |
|
| Velan Capital Investment Management | 352k | $2.5M | 0% | Mar 2026 |
|
| Jane Street | 329k | $2.2M | 835% | Jun 2026 |
|
| SummitTX Capital | 328k | $2.4M | 86% | Mar 2026 |
|
| Aisling Capital Management | 325k | $2.4M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 324k | $2.3M | 107% | Mar 2026 |
|
| Bank of America Corporation | 268k | $1.9M | 100% | Mar 2026 |
|
| Royal Bank of Canada | 261k | $1.9M | 100% | Mar 2026 |
|
| Ally Bridge Group | 252k | $1.7M | -62% | Jun 2026 |
|
| Two Sigma Investments | 221k | $1.5M | 1947% | Jun 2026 |
|
| Marshall Wace | 158k | $1.0M | 0% | Jun 2026 |
|
| CIBC World Markets | 151k | $1.1M | 160% | Mar 2026 |
|
| Acadian Asset Management | 94k | $671k | -40% | Mar 2026 |
|
| TD Waterhouse Canada | 82k | $590k | 751% | Mar 2026 |
|
| Ingalls & Snyder | 76k | $548k | -2% | Mar 2026 |
|
| Goldman Sachs Group | 58k | $384k | 9% | Jun 2026 |
|
| Raymond James Financial | 51k | $366k | -5% | Mar 2026 |
|
| Goodman & Company, Investment Counsel | 50k | $333k | -16% | Jun 2026 |
|
| Stonepine Capital Management | 44k | $288k | 100% | Jun 2026 |
|
| Diadema Partners | 40k | $290k | 100% | Mar 2026 |
|
| Bank Of Montreal | 38k | $276k | 100% | Mar 2026 |
|
| Persistent Asset Partners | 38k | $275k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 35k | $230k | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 31k | $203k | -6% | Jun 2026 |
|
| Geode Capital Management | 26k | $185k | 84% | Mar 2026 |
|
| Axq Capital | 21k | $140k | 34% | Jun 2026 |
|
| Jump Financial | 20k | $131k | 100% | Jun 2026 |
|
| Natixis | 18k | $115k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 14k | $94k | 100% | Jun 2026 |
|
| China Universal Asset Management | 13k | $83k | 25% | Jun 2026 |
|
| TCI Wealth Advisors | 11k | $73k | 0% | Jun 2026 |
|
| Aptus Capital Advisors | 11k | $69k | 0% | Jun 2026 |
|
| Guardian Wealth Advisors, Llc / Nc | 11k | $76k | 5% | Mar 2026 |
|
| Lynx1 Capital Management | 10k | $66k | 100% | Jun 2026 |
|
| Integrated Wealth Concepts | 9.9k | $65k | -18% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 9.1k | $49k | 0% | Mar 2026 |
|
| Morgan Stanley | 8.8k | $64k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 6.4k | $47k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 359.00 | $811.986200 | -39% | Mar 2026 |
|
| Caitong International Asset Management | 52.00 | $344.000800 | 5100% | Jun 2026 |
|
Who sold out of Eupraxia Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squadron Capital Management | Mar 2026 | 680k | $4.9M |
| Hudson Bay Capital Management | Mar 2026 | 92k | $669k |
| Quadrature Capital | Dec 2025 | 43k | $326k |
| XTX Topco | Dec 2025 | 16k | $122k |